Name | [(1S,3S,7S,8S,8aR)-3-hydroxy-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate |
---|---|
Synonyms |
Butanoic acid, 2-methyl-, (1S,3S,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3-hydroxy-7-methyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester, (2S)-
[14C]-Pravastatin lactone UNII:JBE3Z4192Q Pravastatin lactone Pravastatin sodium specified impurity D [EP] pravastatin UNII-JBE3Z4192Q (1S,3S,7S,8S,8aR)-3-Hydroxy-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-7-methyl-1,2,3,7,8,8a-hexahydro-1-naphthalenyl (2S)-2-methylbutanoate HMS2090H21 |
Description | Pravastatin lactone is a potent HMG-CoA inhibitor. Pravastatin Lactone is a metabolite of pravastatin. Pravastatin lactone reduces blood cholesterol levels by inhibiting cholesterol synthesis[1]. |
---|---|
Related Catalog | |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 590.5±50.0 °C at 760 mmHg |
Melting Point | 140-143ºC |
Molecular Formula | C23H34O6 |
Molecular Weight | 406.51 |
Flash Point | 199.5±23.6 °C |
Exact Mass | 406.235535 |
PSA | 93.06000 |
LogP | 1.71 |
Vapour Pressure | 0.0±3.8 mmHg at 25°C |
Index of Refraction | 1.548 |
Precursor 4 | |
---|---|
DownStream 0 |